Author:
Mphonda Steve,Dussault Josée,Bengtson Angela,Gaynes Bradley N.,Go Vivian,Hosseinipour Mina C.,Kulisewa Kazione,Kutengule Anna,Meltzer-Brody Samantha,Udedi Michael,Pence Brian
Abstract
Abstract
Background
Option B + offers lifelong ART to pregnant or breastfeeding mothers, but postpartum loss to HIV care, partially driven by perinatal depression (PND), threatens the impact of this policy. This study aims to understand women’s and providers’ preferences for developing a feasible intervention to address PND and support engagement in HIV care among women living with PND and HIV.
Methods
We conducted a total of 6 focus group discussions (FGDs) involving 4 clinics in Lilongwe District from December 2018 through February 2019. We conducted 2 FGDs each among 3 stakeholder groups: clinical staff, prenatal women, and postnatal women. Perinatal participants were living with HIV and screened positively for PND using the validated Edinburgh Postnatal Depression Scale (EPDS). Clinical staff were nurses who were trained antiretroviral therapy (ART) providers. Interviewers led FGDs in Chichewa using a semi-structured guide. Data were analyzed using deductive and inductive coding in NVivo 12 software.
Results
Women favored ART linkage services, but providers said they already offered such services, with mixed results. Individual counselling was universally supported. A perceived benefit of group counselling was peer support, but there were concerns among women regarding confidentiality and stigma. Women liked mobile appointment reminders but identified low phone ownership as a barrier. Participants recommended home visits as an additional care engagement strategy. Women consistently discussed the need for social support from family members and friends to address PND and support engagement in HIV care.
Conclusion
This study highlights the importance of peer encouragement to support perinatal HIV care engagement among women with HIV and PND. The results from this study can be used to support intervention development to increase HIV care engagement and improve long-term HIV outcomes in women with PND.
Funder
National Institute of Mental Health
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference40 articles.
1. ANTIRETROVIRAL DRUGS FOR TREATING PREGNANT WOMEN FOR THEIR OWN HEALTH AND TO PREVENT HIV INFECTION, IN THEIR INFANTS [Internet]. Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants: Recommendations for a Public Health Approach: 2010 Version. World Health Organization; 2010 [cited 2023 Feb 13]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK304945/
2. Schouten EJ, Jahn A, Midiani D, Makombe SD, Mnthambala A, Chirwa Z, et al. Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. The Lancet. 2011;378(9787):282–4.
3. Muyunda B, Musonda P, Mee P, Todd J, Michelo C. Effectiveness of lifelong ART (option B+) in the Prevention of Mother-to-child transmission of HIV Programme in Zambia: observations based on routinely collected Health Data. Front Public Health. 2020;7:401.
4. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral therapy for the Prevention of HIV-1 transmission. N Engl J Med. 2016;375(9):830–9.
5. Characteristics and outcomes of women initiating ART during pregnancy versus breastfeeding in Option. B + in Malawi | BMC Public Health | Full Text [Internet]. [cited 2023 Feb 13]. Available from: https://bmcpublichealth.biomedcentral.com/articles/https://doi.org/10.1186/s12889-016-3380-7